FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016454360> ?p ?o ?g. }

• W2016454360 endingPage "141" @default.
• W2016454360 startingPage "137" @default.
• W2016454360 abstract "To assess the prevalence and the profile of adverse events (AE) of natalizumab in patients with multiple sclerosis (MS).Data collection from neurologists attending to patients with MS at specialized units in Brazil.Data from 103 patients attending the infusion centers of 16 MS units in 9 Brazilian states were included in the study. The total number of infusions was 1,042. Seventy-nine patients (76.7%) did not present any AE. Twenty-four patients (23.3%) presented only mild AE. There were three major AE, including two deaths. These three occurrences, although not necessarily being drug-related, must be taken into consideration.The profile of AEs for natalizumab shows that 97% of patients have none or only mild AE. However, still due to safety worries, the use of this medication should be restricted to MS units under the care of specialized neurologists." @default.
• W2016454360 created "2016-06-24" @default.
• W2016454360 creator A5002172122 @default.
• W2016454360 creator A5012960163 @default.
• W2016454360 creator A5013100015 @default.
• W2016454360 creator A5014115279 @default.
• W2016454360 creator A5015960447 @default.
• W2016454360 creator A5017083314 @default.
• W2016454360 creator A5023267834 @default.
• W2016454360 creator A5032140683 @default.
• W2016454360 creator A5032186042 @default.
• W2016454360 creator A5035048568 @default.
• W2016454360 creator A5038535180 @default.
• W2016454360 creator A5042529430 @default.
• W2016454360 creator A5046110936 @default.
• W2016454360 creator A5046995565 @default.
• W2016454360 creator A5053273729 @default.
• W2016454360 creator A5053554330 @default.
• W2016454360 creator A5053943700 @default.
• W2016454360 creator A5058784338 @default.
• W2016454360 creator A5059414232 @default.
• W2016454360 creator A5061872684 @default.
• W2016454360 creator A5063327153 @default.
• W2016454360 creator A5069269104 @default.
• W2016454360 creator A5069587271 @default.
• W2016454360 creator A5079114312 @default.
• W2016454360 creator A5081421465 @default.
• W2016454360 creator A5084286476 @default.
• W2016454360 creator A5088327598 @default.
• W2016454360 date "2013-03-01" @default.
• W2016454360 modified "2023-10-18" @default.
• W2016454360 title "Natalizumab adverse events are rare in patients with multiple sclerosis" @default.
• W2016454360 cites W1561057973 @default.
• W2016454360 cites W1988357566 @default.
• W2016454360 cites W1996787636 @default.
• W2016454360 cites W2032017965 @default.
• W2016454360 cites W2044022462 @default.
• W2016454360 cites W2050017740 @default.
• W2016454360 cites W2056494951 @default.
• W2016454360 cites W2073710417 @default.
• W2016454360 cites W2077391034 @default.
• W2016454360 cites W2084656277 @default.
• W2016454360 cites W2087589796 @default.
• W2016454360 cites W2111714917 @default.
• W2016454360 cites W2123289342 @default.
• W2016454360 cites W2150617926 @default.
• W2016454360 doi "https://doi.org/10.1590/s0004-282x2013000300002" @default.
• W2016454360 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23563711" @default.
• W2016454360 hasPublicationYear "2013" @default.
• W2016454360 type Work @default.
• W2016454360 sameAs 2016454360 @default.
• W2016454360 citedByCount "13" @default.
• W2016454360 countsByYear W20164543602013 @default.
• W2016454360 countsByYear W20164543602014 @default.
• W2016454360 countsByYear W20164543602015 @default.
• W2016454360 countsByYear W20164543602016 @default.
• W2016454360 countsByYear W20164543602017 @default.
• W2016454360 countsByYear W20164543602019 @default.
• W2016454360 countsByYear W20164543602020 @default.
• W2016454360 countsByYear W20164543602021 @default.
• W2016454360 crossrefType "journal-article" @default.
• W2016454360 hasAuthorship W2016454360A5002172122 @default.
• W2016454360 hasAuthorship W2016454360A5012960163 @default.
• W2016454360 hasAuthorship W2016454360A5013100015 @default.
• W2016454360 hasAuthorship W2016454360A5014115279 @default.
• W2016454360 hasAuthorship W2016454360A5015960447 @default.
• W2016454360 hasAuthorship W2016454360A5017083314 @default.
• W2016454360 hasAuthorship W2016454360A5023267834 @default.
• W2016454360 hasAuthorship W2016454360A5032140683 @default.
• W2016454360 hasAuthorship W2016454360A5032186042 @default.
• W2016454360 hasAuthorship W2016454360A5035048568 @default.
• W2016454360 hasAuthorship W2016454360A5038535180 @default.
• W2016454360 hasAuthorship W2016454360A5042529430 @default.
• W2016454360 hasAuthorship W2016454360A5046110936 @default.
• W2016454360 hasAuthorship W2016454360A5046995565 @default.
• W2016454360 hasAuthorship W2016454360A5053273729 @default.
• W2016454360 hasAuthorship W2016454360A5053554330 @default.
• W2016454360 hasAuthorship W2016454360A5053943700 @default.
• W2016454360 hasAuthorship W2016454360A5058784338 @default.
• W2016454360 hasAuthorship W2016454360A5059414232 @default.
• W2016454360 hasAuthorship W2016454360A5061872684 @default.
• W2016454360 hasAuthorship W2016454360A5063327153 @default.
• W2016454360 hasAuthorship W2016454360A5069269104 @default.
• W2016454360 hasAuthorship W2016454360A5069587271 @default.
• W2016454360 hasAuthorship W2016454360A5079114312 @default.
• W2016454360 hasAuthorship W2016454360A5081421465 @default.
• W2016454360 hasAuthorship W2016454360A5084286476 @default.
• W2016454360 hasAuthorship W2016454360A5088327598 @default.
• W2016454360 hasBestOaLocation W20164543601 @default.
• W2016454360 hasConcept C118552586 @default.
• W2016454360 hasConcept C126322002 @default.
• W2016454360 hasConcept C197934379 @default.
• W2016454360 hasConcept C2780640218 @default.
• W2016454360 hasConcept C2781004633 @default.
• W2016454360 hasConcept C71924100 @default.
• W2016454360 hasConceptScore W2016454360C118552586 @default.
• W2016454360 hasConceptScore W2016454360C126322002 @default.
• W2016454360 hasConceptScore W2016454360C197934379 @default.

• next